Sabzevari Helen

Precigen, Inc.

President and CEO, Director

Avg. Two Year Performance

No Purchase Track Record

2% Avg. Sale Return 1% Compound

Holdings: 2.22M shares

Last Three Months: 20-Jan-24 -- 19-Apr-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Insider Trading Sentiment: Accumulate

Company Sentiment

Biotechnology

Drugs

Two Year Chart

20-Apr-22 -- 19-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions